Cathie Wood: portfolio of ARK Investment Management
Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.
Source: 13F filing with the US Securities and Exchange Commission dated May 7, 2025. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q1 2025. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 10.0B USD
- Positions
- 196
- Share of the ten largest
- 48.5%
The ten largest positions Q1 2025
- Tesla, Inc. 8.5%▼ −0.9%
- Roku Inc 6.1%▼ −19.0%
- Palantir Technologies 5.3%▼ −19.4%
- Roblox 5.3%▼ −10.6%
- Coinbase 5.3%▲ +1.1%
- Robinhood Markets 4.3%▼ −20.6%
- Shopify 4.2%▼ −1.3%
- Tempus AI 3.6%▲ +35.9%
- CRISPR Therapeutics AG 3.5%▲ +13.3%
- Twist Bioscience Corp 2.5%▲ +11.5%
Show all positions of this quarter
Choose a quarter (40 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
All positions Q1 2025
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| COIN Coinbase | 5.3% | 3,069,107 | 528.6M USD | +1.1% increased | Q2 2021 16 quarters |
| TEM Tempus AI | 3.6% | 7,501,399 | 361.9M USD | +35.9% increased | Q2 2024 4 quarters |
| CRISPR Therapeutics AG | 3.5% | 10,165,400 | 345.9M USD | +13.3% increased | Q2 2017 32 quarters |
| Twist Bioscience Corp | 2.5% | 6,241,595 | 245.0M USD | +11.5% increased | Q2 2019 24 quarters |
| AMZN Amazon | 2.0% | 1,053,516 | 200.4M USD | +17.7% increased | Q4 2016 or earlier 34 quarters |
| TER Teradyne | 1.9% | 2,243,590 | 185.3M USD | +16.7% increased | Q4 2016 or earlier 34 quarters |
| Recursion Pharmaceuticals Inc | 1.8% | 34,815,502 | 184.2M USD | +7.6% increased | Q2 2021 16 quarters |
| PagerDuty Inc | 1.7% | 9,170,848 | 167.6M USD | +1.9% increased | Q1 2020 21 quarters |
| Beam Therapeutics Inc | 1.7% | 8,480,089 | 165.6M USD | +20.0% increased | Q4 2020 18 quarters |
| AMD Advanced Micro Devices | 1.5% | 1,422,471 | 146.1M USD | +17.9% increased | Q1 2023 9 quarters |
| Iridium Communications Inc | 1.3% | 4,891,677 | 133.6M USD | +95.1% increased | Q3 2019 23 quarters |
| Natera Inc | 1.3% | 943,094 | 133.4M USD | +6.2% increased | Q1 2024 5 quarters |
| Gitlab Inc | 1.1% | 2,426,332 | 114.0M USD | +109.1% increased | Q3 2024 3 quarters |
| 10X Genomics Inc | 1.1% | 12,845,713 | 112.1M USD | +7.5% increased | Q2 2020 20 quarters |
| DE Deere & Company | 1.1% | 225,220 | 105.7M USD | +189.2% increased | Q3 2017 31 quarters |
| Intellia Therapeutics Inc | 0.9% | 13,011,015 | 92.5M USD | +3.8% increased | Q4 2016 or earlier 34 quarters |
| TTD The Trade Desk | 0.9% | 1,560,191 | 85.4M USD | +22.7% increased | Q2 2023 8 quarters |
| ILMN Illumina, Inc. | 0.7% | 895,319 | 71.0M USD | +30.5% increased | Q4 2024 2 quarters |
| TRMB Trimble Inc. | 0.5% | 826,208 | 54.2M USD | +0.3% increased | Q4 2016 or earlier 34 quarters |
| Schrodinger Inc/United States | 0.5% | 2,294,519 | 45.3M USD | +3.9% increased | Q2 2020 20 quarters |
| Pacific Biosciences of Califor | 0.4% | 36,478,441 | 43.0M USD | +1.2% increased | Q3 2019 23 quarters |
| TSM Taiwan Semiconductor Manufacturing (ADR) | 0.4% | 226,048 | 37.5M USD | +4.0% increased | Q2 2023 8 quarters |
| AeroVironment Inc | 0.3% | 281,323 | 33.5M USD | +6.7% increased | Q4 2016 or earlier 34 quarters |
| QCOM Qualcomm | 0.3% | 198,173 | 30.4M USD | +86.5% increased | Q1 2024 5 quarters |
| Ibotta Inc | 0.3% | 704,308 | 29.7M USD | +299.8% increased | Q2 2024 4 quarters |
| Absci Corp | 0.3% | 10,955,089 | 27.5M USD | +32.5% increased | Q1 2024 5 quarters |
| Personalis Inc | 0.3% | 7,188,197 | 25.2M USD | +6.1% increased | Q2 2019 24 quarters |
| LHX L3Harris | 0.2% | 114,701 | 24.0M USD | +110.8% increased | Q1 2021 17 quarters |
| Blade Air Mobility Inc | 0.2% | 8,140,644 | 22.2M USD | +1.1% increased | Q2 2021 16 quarters |
| Arcturus Therapeutics Holdings | 0.2% | 2,008,480 | 21.3M USD | +3.9% increased | Q2 2019 24 quarters |
| JOBY Joby Aviation | 0.2% | 3,442,843 | 20.7M USD | +1.6% increased | Q3 2021 15 quarters |
| GOOG Alphabet Inc. (Class C) | 0.2% | 130,762 | 20.4M USD | +1.9% increased | Q2 2020 20 quarters |
| Nurix Therapeutics Inc | 0.2% | 1,590,910 | 18.9M USD | +4.0% increased | Q4 2021 14 quarters |
| Aurora Innovation Inc | 0.2% | 2,461,686 | 16.6M USD | +2.0% increased | Q3 2024 3 quarters |
| Butterfly Network Inc | 0.2% | 7,023,980 | 16.0M USD | +16.8% increased | Q1 2021 17 quarters |
| DDOG Datadog | 0.1% | 139,617 | 13.9M USD | +9.7% increased | Q2 2024 4 quarters |
| P Everpure | 0.1% | 299,787 | 13.3M USD | +49.8% increased | Q2 2023 8 quarters |
| 908 Devices Inc | 0.1% | 2,899,347 | 13.0M USD | +4.0% increased | Q4 2020 18 quarters |
| Cameco Corp | 0.1% | 310,821 | 12.8M USD | +57.0% increased | Q3 2023 7 quarters |
| VRTX Vertex Pharmaceuticals | 0.1% | 26,344 | 12.8M USD | +3.9% increased | Q3 2020 19 quarters |
| BWX Technologies Inc | 0.1% | 121,764 | 12.0M USD | +28.3% increased | Q4 2024 2 quarters |
| SNPS Synopsys | 0.1% | 26,617 | 11.4M USD | +1.5% increased | Q1 2020 21 quarters |
| INCY Incyte | 0.1% | 168,106 | 10.2M USD | +3.9% increased | Q4 2016 or earlier 34 quarters |
| ISRG Intuitive Surgical | < 0.1% | 19,835 | 9.8M USD | +2.0% increased | Q2 2018 28 quarters |
| REGN Regeneron Pharmaceuticals | < 0.1% | 13,694 | 8.7M USD | +3.8% increased | Q4 2020 18 quarters |
| Symbotic Inc | < 0.1% | 393,293 | 7.9M USD | +106.9% increased | Q4 2024 2 quarters |
| CAT Caterpillar Inc. | < 0.1% | 20,857 | 6.9M USD | 0.0% increased | Q1 2020 21 quarters |
| Compass Pathways Plc | < 0.1% | 1,804,803 | 5.2M USD | +4.0% increased | Q3 2022 11 quarters |
| ARK Innovation ETF | < 0.1% | 82,932 | 3.9M USD | +148.8% increased | Q3 2024 3 quarters |
| Standard BioTools Inc | < 0.1% | 3,452,890 | 3.7M USD | +3.9% increased | Q1 2024 5 quarters |
| HPQ HP Inc. | < 0.1% | 102,721 | 2.8M USD | +2.0% increased | Q4 2016 or earlier 34 quarters |
| DENTSPLY SIRONA Inc | < 0.1% | 160,773 | 2.4M USD | +17.1% increased | Q3 2023 7 quarters |
| Check Point Software Technolog | < 0.1% | 10,440 | 2.4M USD | +18.7% increased | Q4 2017 30 quarters |
| Inmode Ltd | < 0.1% | 116,709 | 2.1M USD | +10.3% increased | Q4 2019 22 quarters |
| UroGen Pharma Ltd | < 0.1% | 185,790 | 2.1M USD | +32.6% increased | Q4 2017 30 quarters |
| Sapiens International Corp NV | < 0.1% | 74,531 | 2.0M USD | +50.7% increased | Q3 2018 27 quarters |
| Monday.com Ltd | < 0.1% | 8,030 | 2.0M USD | +25.7% increased | Q3 2021 15 quarters |
| Radware Ltd | < 0.1% | 89,327 | 1.9M USD | +13.5% increased | Q4 2017 30 quarters |
| Nice Ltd | < 0.1% | 11,883 | 1.8M USD | +17.2% increased | Q4 2017 30 quarters |
| Brainsway Ltd | < 0.1% | 188,328 | 1.8M USD | +7.3% increased | Q4 2024 2 quarters |
| MediWound Ltd | < 0.1% | 106,930 | 1.7M USD | +6.7% increased | Q3 2024 3 quarters |
| Taboola.com Ltd | < 0.1% | 539,207 | 1.6M USD | +6.4% increased | Q1 2022 13 quarters |
| Playtika Holding Corp | < 0.1% | 275,372 | 1.4M USD | +14.6% increased | Q3 2021 15 quarters |
| ADBE Adobe Inc. | < 0.1% | 862 | 330.6K USD | +78.5% increased | Q2 2024 4 quarters |
| ATI Inc | < 0.1% | 1,545 | 80.4K USD | +8.4% increased | Q4 2016 or earlier 34 quarters |
| Eastman Chemical Co | < 0.1% | 884 | 77.9K USD | +7.0% increased | Q4 2016 or earlier 34 quarters |
| Avient Corp | < 0.1% | 1,932 | 71.8K USD | +9.9% increased | Q3 2023 7 quarters |
| iShares Russell 1000 ETF | < 0.1% | 13 | 3.9K USD | +18.2% increased | Q4 2024 2 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Financials 12.2%
- Technology 12.2%
- Consumer Discretionary 10.6%
- Industrials 3.6%
- Communication Services 2.8%
- Health Care 1.4%
- not in our coverage 57.0%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors